Amgen

Amgen is a top biotechnology company in the globe as well as one of the the largest biotech companies in Germany. Amgen is a values-driven firm that uses research and innovation to turn fresh ideas and discoveries into medications for patients suffering from critical illnesses. Amgen is dedicated to unlocking the promise of biology for patients suffering from serious illnesses through the discovery, development, production, and delivery of novel human medicines. To unravel the complexity of disease and grasp the principles of human biology, this method begins with technologies such as advanced human genetics.

Amgen employs its expertise in areas with high unmet medical need to develop treatments that improve patients' health and quality of life. Since its founding in 1980, biotechnology pioneer Amgen has become a global leader among independent biotechnology companies, serving millions of patients around the world and developing a series of potentially game-changing drugs. It operates in close to a hundred different nations and territories, and its ground-breaking medicines have given hope to millions of individuals struggling with serious conditions like cancer, heart disease, osteoporosis, asthma, rheumatoid arthritis, and many more.

Millions of severely ill patients throughout the world rely on the consistent production of injectable or intravenous biological treatments. As a world-renowned leader in the production of biologics, Amgen has a history of providing life-saving treatments to those in need. Amgen's mission is to help people by turning the promise of science and biotechnology into medications that can improve or save patients' health.

Founded: 1989
Headquarters: Munich, Germany
Website: https://www.amgen.de/